Cas No.: | 439081-18-2 |
Chemical Name: | (S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide |
Synonyms: | (S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;BIBW 2992;Afatinib;(E)-N-(7-((S)-tetrahydrofuran-3-yloxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-2-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-;Afatinib ( BIBW-2992, BIBW 2992, Tovok®);Afatinib (BIBW2992);BIBW;BIBW-2992;BIBW2992 Afatinib;N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide;(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;2992;Biapenern;CL186815;L627;LJC10627;Omegacin;Tovok |
SMILES: | CN(C)C\C=C\C(=O)NC1=C(OC2COCC2)C=C3C(=C1)C(=NC=N3)NC4C=C(Cl)C(F)=CC=4 |
Formula: | C24H25N5O3FCl |
M.Wt: | 485.9384 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | For the detailed information about the solubility of Afatinib (BIBW2992) in water, the solubility of Afatinib (BIBW2992) in DMSO, the solubility of Afatinib (BIBW2992) in PBS buffer, the animal experiment(test) of Afatinib (BIBW2992),the in vivo,in vitro and clinical trial test of Afatinib (BIBW2992),the cell experiment(test) of Afatinib (BIBW2992),the IC50, EC50 and Affinity of Afatinib (BIBW2992), please contact DC Chemicals. |